1. Home
  2. RDW vs SPRY Comparison

RDW vs SPRY Comparison

Compare RDW & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDW
  • SPRY
  • Stock Information
  • Founded
  • RDW 2020
  • SPRY 2015
  • Country
  • RDW United States
  • SPRY United States
  • Employees
  • RDW N/A
  • SPRY N/A
  • Industry
  • RDW Military/Government/Technical
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDW Industrials
  • SPRY Health Care
  • Exchange
  • RDW Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • RDW 1.5B
  • SPRY 1.4B
  • IPO Year
  • RDW N/A
  • SPRY N/A
  • Fundamental
  • Price
  • RDW $14.32
  • SPRY $14.43
  • Analyst Decision
  • RDW Strong Buy
  • SPRY Strong Buy
  • Analyst Count
  • RDW 6
  • SPRY 4
  • Target Price
  • RDW $17.71
  • SPRY $28.75
  • AVG Volume (30 Days)
  • RDW 1.8M
  • SPRY 1.5M
  • Earning Date
  • RDW 05-12-2025
  • SPRY 05-14-2025
  • Dividend Yield
  • RDW N/A
  • SPRY N/A
  • EPS Growth
  • RDW N/A
  • SPRY N/A
  • EPS
  • RDW N/A
  • SPRY N/A
  • Revenue
  • RDW $277,704,000.00
  • SPRY $97,122,000.00
  • Revenue This Year
  • RDW $52.69
  • SPRY $1.49
  • Revenue Next Year
  • RDW $42.06
  • SPRY $141.68
  • P/E Ratio
  • RDW N/A
  • SPRY N/A
  • Revenue Growth
  • RDW 1.36
  • SPRY 971120.00
  • 52 Week Low
  • RDW $4.84
  • SPRY $7.55
  • 52 Week High
  • RDW $26.66
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • RDW 60.80
  • SPRY 53.24
  • Support Level
  • RDW $11.33
  • SPRY $14.32
  • Resistance Level
  • RDW $16.56
  • SPRY $15.50
  • Average True Range (ATR)
  • RDW 1.49
  • SPRY 0.84
  • MACD
  • RDW 0.28
  • SPRY 0.12
  • Stochastic Oscillator
  • RDW 63.16
  • SPRY 72.21

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's Heritage plus Innovation strategy enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: